The relationships between ethnoracial identity, Aβ positivity, APOE ε4, and medial temporal lobe tau PET
Alzheimer's & Dementia · 2026
DOI: 10.1002/alz.71226 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Koral V Wheeler und 15 weiteren Autor:innen. Beteiligte Einrichtung: Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Los Angeles, California, US…. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Apolipoprotein E4, Cognitive Dysfunction, tau Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute on Aging of the National Institutes of Health, Office of The Director of the National Institutes of Health.
Abstract (Originalsprache)
INTRODUCTION Clarifying relationships between amyloid, tau, and cognition is crucial to understanding dementia risk, but has been mainly performed in non‐Hispanic White (NHW) participants. It is unknown whether findings are generalizable to other ethnoracial groups. METHODS We evaluated relationships between amyloid‐β (Aβ) positivity, apolipoprotein E allele ( APOE) ε4, tau‐positron emission tomography (PET) 18 F‐PI‐2620, and cognitive performance in 1181 cognitively unimpaired (451 NHW, 353 Hispanic, and 377 Black) and 383 mild cognitively impaired (85 NHW, 129 Hispanic, and 169 Black) participants from the Health and Aging Brain Study‐Health Disparities. RESULTS Black ( β = 0.28, p < 0.001) and Hispanic ( β = 0.34, p < 0.001) participants had higher medial temporal lobe (MTL) tau than NHW participants; however, findings were attenuated when accounting for choroid plexus off‐target binding. Hispanic participants showed higher tau in lateral temporal regions compared to NHW and Black participants; however, reducing meningeal off‐target binding through erosion demonstrated similar lateral temporal tau across groups. DISCUSSION Factors other than amyloid and tau may impact cognition in Black participants. PI2620 off‐target ethnoracial differences should be investigated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
- University of North Texas Health Science Center Fort Worth Texas USA, Fort Worth, Texas, USA.
- Department of Psychology, University of Texas at Austin, Austin, Texas, USA.
- Department of Psychiatry, Neurology, and Epidemiology and Biostatistics, University of California San Francisco School of Medicine, San Francisco, California, USA.
Förderung
- National Institute on Aging of the National Institutes of Health
- Office of The Director of the National Institutes of Health
Zitieren
APA
Wheeler, K. V., Tennant, V. R., Lee, N. N., Hand, M. W., Ganesan, S., Walsh, P., Tubi, M., Terner, J. A., Hall, B., Davison, M., Toga, A. W., O'Bryant, S., Clark, A. L., Yaffe, K., Braskie, M. N., & HABS‐HD Study Team (2026). The relationships between ethnoracial identity, Aβ positivity, APOE ε4, and medial temporal lobe tau PET. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71226
Vancouver
Wheeler KV, Tennant VR, Lee NN, Hand MW, Ganesan S, Walsh P, et al. The relationships between ethnoracial identity, Aβ positivity, APOE ε4, and medial temporal lobe tau PET. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71226
BibTeX
@article{Wheeler2026,
author = {Wheeler, Koral V and Tennant, Victoria R and Lee, Noelle N and Hand, Maxwell W and Ganesan, Suchita and Walsh, Patrick and Tubi, Meral and Terner, Jamie A and Hall, Brandon and Davison, Marylan and Toga, Arthur W and O'Bryant, Sid and Clark, Alexandra L and Yaffe, Kristine and Braskie, Meredith N and HABS‐HD Study Team, HABS‐HD Study Team},
title = {The relationships between ethnoracial identity, Aβ positivity, APOE ε4, and medial temporal lobe tau PET},
journal = {Alzheimer's & Dementia},
year = {2026},
doi = {10.1002/alz.71226}
}
EUVIMED